1. Home
  2. KLRS vs OPTN Comparison

KLRS vs OPTN Comparison

Compare KLRS & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLRS
  • OPTN
  • Stock Information
  • Founded
  • KLRS 2019
  • OPTN 2010
  • Country
  • KLRS United States
  • OPTN United States
  • Employees
  • KLRS N/A
  • OPTN N/A
  • Industry
  • KLRS Biotechnology: Biological Products (No Diagnostic Substances)
  • OPTN Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLRS Health Care
  • OPTN Health Care
  • Exchange
  • KLRS Nasdaq
  • OPTN Nasdaq
  • Market Cap
  • KLRS 57.5M
  • OPTN 55.4M
  • IPO Year
  • KLRS N/A
  • OPTN 2017
  • Fundamental
  • Price
  • KLRS $6.99
  • OPTN $9.17
  • Analyst Decision
  • KLRS Buy
  • OPTN Hold
  • Analyst Count
  • KLRS 1
  • OPTN 3
  • Target Price
  • KLRS N/A
  • OPTN $9.00
  • AVG Volume (30 Days)
  • KLRS 52.0K
  • OPTN 141.6K
  • Earning Date
  • KLRS 05-15-2025
  • OPTN 05-13-2025
  • Dividend Yield
  • KLRS N/A
  • OPTN N/A
  • EPS Growth
  • KLRS N/A
  • OPTN N/A
  • EPS
  • KLRS N/A
  • OPTN N/A
  • Revenue
  • KLRS N/A
  • OPTN $78,226,000.00
  • Revenue This Year
  • KLRS N/A
  • OPTN $30.49
  • Revenue Next Year
  • KLRS N/A
  • OPTN $13.51
  • P/E Ratio
  • KLRS N/A
  • OPTN N/A
  • Revenue Growth
  • KLRS N/A
  • OPTN 10.20
  • 52 Week Low
  • KLRS $5.87
  • OPTN $4.82
  • 52 Week High
  • KLRS $24.15
  • OPTN $20.03
  • Technical
  • Relative Strength Index (RSI)
  • KLRS N/A
  • OPTN 76.77
  • Support Level
  • KLRS N/A
  • OPTN $8.75
  • Resistance Level
  • KLRS N/A
  • OPTN $9.28
  • Average True Range (ATR)
  • KLRS 0.00
  • OPTN 0.14
  • MACD
  • KLRS 0.00
  • OPTN -0.11
  • Stochastic Oscillator
  • KLRS 0.00
  • OPTN 79.25

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

Share on Social Networks: